ISA Pharmaceuticals to Attend Multiple In Person Conferences in Early 2022

On February 17, 2022 ISA Pharmaceuticals reported that it will be attending the following in person scientific and business conferences from February through to April 2022 (subject to travel restrictions), in addition to virtual conferences (Press release, ISA Pharmaceuticals, FEB 17, 2022, View Source [SID1234608210]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioCapital Europe

Date: 10 March 2022, Amsterdam

American Association for Cancer Research (AACR) (Free AACR Whitepaper) annual meeting

Date: 8-13 April 2022, New Orleans

2nd Chronic HBV drug development

Date: 25-27 April 2022, Boston

If you would like to meet with the ISA Pharmaceutical team at any of the above events, please contact us!